Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Gennex Laboratories Ltd.	Balance Sheet

BSE: 531739ISIN: INE509C01026INDUSTRY: Pharmaceuticals

BSE

Rs 11.88

Open: 11.88

Today's Range 11.71

11.96

+0.09 (+ 0.76 %)

Prev Close: 11.79

52 Week Range 11.15

29.00

You can view the Balance Sheet for the last 5 years.

Market Cap. (Rs.)	288.62 Cr.	P/BV	1.59	Book Value (Rs.)	7.49
52 Week High/Low (Rs.)	29/11	FV/ML	1/1	P/E(X)	15.92
Bookclosure	30/09/2024	EPS (Rs.)	0.75	Div Yield (%)	0.00

(Rs. in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00
No. of Equity Shares (in Lacs)	2274.48	2274.48	1766.43	1265.03	1265.03

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	22.74	22.74	18.02	12.65	12.65
Total Share Capital	22.74	22.74	18.02	12.65	12.65

Reserves and Surplus	163.94	141.92	62.33	31.16	27.06
Total Reserves and Surplus	163.94	141.92	62.33	31.16	27.06
Money Received Against Share Warrants	0.00	5.72	0.00	0.00	0.00
Total Shareholders Funds	186.69	170.38	80.35	43.82	39.71
Minority Interest	7.90	6.08	6.17	0.00	0.00

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.15
Other Long Term Liabilities	16.89	13.22	16.29	0.00	0.00
Total Non-Current Liabilities	16.89	13.22	16.29	0.00	0.15

CURRENT LIABILITIES
Short Term Borrowings	10.22	5.72	1.05	10.12	7.36
Trade Payables	13.16	15.18	7.08	7.74	5.94
Other Current Liabilities	20.58	18.95	20.77	5.71	5.18
Short Term Provisions	0.59	0.45	0.61	0.63	0.56
Total Current Liabilities	44.55	40.30	29.51	24.21	19.04

Total Capital And Liabilities	256.04	229.99	132.32	68.03	58.90

ASSETS
NON-CURRENT ASSETS
Tangible Assets	56.62	52.70	76.71	13.70	14.13
Intangible Assets	2.94	2.94	6.11	0.00	0.00
Capital Work-In-Progress	5.22	2.32	0.02	0.00	0.00
Fixed Assets	64.78	57.96	82.84	13.70	14.13
Non-Current Investments	0.00	0.01	0.01	6.83	6.83
Deferred Tax Assets [Net]	0.18	0.23	0.14	0.00	0.00
Other Non-Current Assets	9.95	9.97	0.65	0.32	0.28
Total Non-Current Assets	74.91	68.17	83.63	20.84	21.23


CURRENT ASSETS
Inventories	35.94	25.17	15.69	7.74	5.02
Trade Receivables	14.16	17.81	9.42	11.31	8.95
Cash And Cash Equivalents	55.57	60.97	15.06	8.31	1.07
OtherCurrentAssets	75.46	57.85	8.51	19.82	22.63
Total Current Assets	181.13	161.81	48.68	47.18	37.67

Total Assets	256.04	229.99	132.32	68.03	58.90

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	0.98	0.74	0.74	1.70

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	0.01	0.01	6.83	6.83

Market

Derivatives

Mutual Fund

IPO

Quick Links

Gennex Laboratories Ltd.

Balance Sheet